Lawsuit Claims Aetna Violated Confidentiality Laws by Sending Envelope with Glassine Window
Last Updated on May 8, 2018
Doe v. Aetna, Inc.
Filed: September 25, 2017 ◆§ 3:17-cv-01947-H-JLB
An unnamed plaintiff alleges Aetna unlawfully disclosed his private medical information by mailing him documents in an envelope with a glassine window.
A proposed class action case filed in California by a “John Doe” plaintiff alleges Aetna, Inc. violated confidentiality laws after it sent the man a letter pertaining to his HIV medications in an “envelope with a large glassine window.” The 17-page complaint alleges this glassine window exposed the contents of the letter - an unlawful and unauthorized disclosure of the plaintiff’s personal and confidential medical information. Included in the letter, the case says, was the plaintiff’s name and reference to his medical diagnosis, as well as prescription and insurance and billing information.
The below photograph was included in the complaint:
From the lawsuit:
The case then says that on or around August 23, 2017, Aetna sent the plaintiff and proposed class members written notice of the privacy breach that occurred as a result of the company’s letter pictured above.
Video Game Addiction Lawsuits
If your child suffers from video game addiction — including Fortnite addiction or Roblox addiction — you may be able to take legal action. Gamers 18 to 22 may also qualify.
Learn more:Video Game Addiction Lawsuit
Depo-Provera Lawsuits
Anyone who received Depo-Provera or Depo-Provera SubQ injections and has been diagnosed with meningioma, a type of brain tumor, may be able to take legal action.
Read more: Depo-Provera Lawsuit
How Do I Join a Class Action Lawsuit?
Did you know there's usually nothing you need to do to join, sign up for, or add your name to new class action lawsuits when they're initially filed?
Read more here: How Do I Join a Class Action Lawsuit?
Stay Current
Sign Up For
Our Newsletter
New cases and investigations, settlement deadlines, and news straight to your inbox.
Before commenting, please review our comment policy.